Indication
Gallbladder Cancer AJCC v7
3 clinical trials
3 products
1 drug
Clinical trial
A Phase Ib Study of Guadecitabine (SGI-110) and Durvalumab (MEDI 4736) in Patients With Advanced Hepatocellular Carcinoma, Pancreatic Adenocarcinoma, and Cholangiocarcinoma/Gallbladder CancerStatus: Active (not recruiting), Estimated PCD: 2021-03-02
Drug
AN0025Product
GuadecitabineClinical trial
A Phase II Study of Ramucirumab for Advanced, Pre-Treated Biliary CancersStatus: Completed, Estimated PCD: 2022-06-29
Product
RamucirumabClinical trial
Phase II Trial of Trifluridine/Tipiracil (FTD/TPI (TAS-102)) in Biliary Tract CancersStatus: Completed, Estimated PCD: 2018-11-30
Product
Trifluridine/Tipiracil